Betty Betsy Lee Mangel thegazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thegazette.com Daily Mail and Mail on Sunday newspapers.
Large Gene panel helpful in identifying cancer-causing genes ANI | Updated: Feb 06, 2021 14:14 IST
Washington [US], February 6 (ANI): Researchers during a recent study have found a gene panel that includes all genes known to potentially cause cancer. This can be readily adopted for use in clinical laboratories to diagnose acute myeloid leukemia, or AML.
The 523-gene panel, which looks about 10 times the number of cancer-causing genes, developed by San Diego-based biotech company Illumina, is currently used to diagnose and fine-tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia. The investigators reported in the journal PLOS ONE.
Credit: Kim Ratliff, Augusta University Photographer
AUGUSTA, Ga. (Feb. 1, 2020) - A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report.
The 523-gene panel, developed by San Diego-based biotech company Illumina, which includes all genes known to potentially cause cancer, can be readily adopted for use in clinical laboratories to diagnose acute myeloid leukemia, or AML, the investigators report in the journal
PLOS ONE.
Identifying more genetic mutations in an individual s cancer also enables more targeted treatment for that patient, they say. That includes finding mutations not previously associated with their cancer type, which opens the door to using drugs targeting those mutations that have traditionally been used against other cancers.
Dr. Han Myint Appointed as NextCure’s Chief Medical Officer
January 14, 2021 16:05 ET | Source: NextCure NextCure Beltsville, Maryland, UNITED STATES
BELTSVILLE, Md., Jan. 14, 2021 (GLOBE NEWSWIRE) NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the appointment of Dr. Han Myint, MD, FACP as chief medical officer. Dr. Myint will oversee the clinical development of key products in NextCure’s product pipeline, including NC318, a first-in-class immunomedicine, targeting Siglec-15 (S15), and NC410, recombinant LAIR-2 fusion protein designed to block immune suppression mediated by the immune modulator LAIR-1. Prior to joining NextCure, Dr. Myint held senior roles at both Celgene (a Bristol Myers Squibb Company) and NexImmune Inc.
Nurse friends and family had a parade to honor Carla Lee, who is retiring in January 2021. Author: KGW Staff Updated: 4:51 PM EST January 4, 2021
PORTLAND, Ore. An Oregon nurse of more than 40 years is getting a special sendoff for her retirement.
Nurse friends and family had a parade for Carla Lee, a registered nurse who worked at Legacy Emanuel and Good Samaritan Medical Center.
Her supervisor, Mika Sunago, organized the parade, with a group meeting in NE Portland Saturday morning to drive past Lee s house.
Lee started her nursing career in 1976. She began work at Legacy in 1981 in the oncology unit.